Skip to main content
PMC home page
Frontiers in Molecular Biosciences logoLink to Frontiers in Molecular Biosciences
. 2023 Oct 31;10:1325104. doi: 10.3389/fmolb.2023.1325104

Corrigendum: VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK

Aurore C Poirier 1,*, Ruben D Riaño Moreno 2, Leona Takaindisa 1, Jessie Carpenter 2, Jai W Mehat 3, Abi Haddon 4,†, Mohammed A Rohaim 5, Craig Williams 6, Peter Burkhart 6, Chris Conlon 7, Matthew Wilson 7, Matthew McClumpha 7, Anna Stedman 1, Guido Cordoni 1, Manoharanehru Branavan 8, Mukunthan Tharmakulasingam 9, Nouman S Chaudhry 9, Nicolas Locker 3,†, Anil Fernando 9,†, Wamadeva Balachandran 8, Mark Bullen 7, Nadine Collins 4, David Rimer 2, Daniel L Horton 1, Muhammad Munir 5, Roberto M La Ragione 1,3,*
PMCID: PMC10646178  PMID: 38028554

In the published article, there was an error in the Article title. Instead of “VIDIIA Hunter diagnostic platform: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostics approved for medical use in the UK,” it should be “VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Articles from Frontiers in Molecular Biosciences are provided here courtesy of Frontiers Media SA

RESOURCES